Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
短名 | |
Journal Impact | 5.26 |
国际分区 | MEDICINE, RESEARCH & EXPERIMENTAL(Q1) |
期刊索引 | SCI Q1中科院 2 区 |
ISSN | 1350-6129, 1744-2818 |
h-index | 72 |
国内分区 | 医学(2区)医学生化与分子生物学(2区)医学医学内科(2区)医学医学研究与实验(2区) |
涉及主题 | 医学生物病理内科学化学淀粉样变性遗传学内分泌学生物化学植物淀粉样蛋白(真菌学)无机化学疾病免疫学转甲状腺素外科抗体基因物理免疫球蛋白轻链 |
出版信息 | 出版商: Informa Healthcare,出版周期: Quarterly,期刊类型: journal |
基本数据 | 创刊年份: 1994,原创研究文献占比: 97.83%,自引率:5.80%, Gold OA占比: 31.25% |
平均审稿周期 | 网友分享经验:较慢,6-12周 |
平均录用比例 | 网友分享经验:一般 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Modified ex-PRESS technique versus Ahmed glaucoma valve as primary glaucoma surgery for hereditary transthyretin amyloidosis glaucoma
2024-9-10
No body fits in the test tube – the case of transthyretin
2024-9-8
International prevalence of transthyretin amyloid cardiomyopathy in high-risk patients with heart failure and preserved or mildly reduced ejection fraction
2024-9-8
T2-relaxometry in a large cohort of hereditary transthyretin amyloidosis with polyneuropathy
2024-9-2
A report from the European Proteomics Amyloid Network (EPAN)
2024-8-22
Brain MRI in patients with V30M hereditary transthyretin amyloidosis
2024-8-17
Anti-PEG antibodies associated with reduced therapeutic effect of patisiran in patients with hereditary transthyretin amyloidosis
2024-8-10
ELISA-4-amyloid: diagnostic accuracy of an ELISA panel for typing the four main types of systemic amyloidosis in subcutaneous abdominal fat tissue samples
2024-8-6
Successes in translation
2024-8-5
Clinical and molecular insights into A97S variants in hereditary transthyretin amyloid polyneuropathy in South China
2024-7-31
Altered connectivity of central autonomic network: effects of dysautonomia in hereditary transthyretin amyloidosis with polyneuropathy
2024-7-24
Response to therapy with tafamidis 61 mg in patients with cardiac transthyretin amyloidosis: real-world experience since approval
2024-7-17
Glaucoma is not seen at a higher prevalence in age-related transthyretin amyloidosis after race stratification
2024-7-14
Delayed identification of monoclonal protein is associated with early death in isolated cardiac AL amyloidosis
2024-7-11
Internalisation of immunoglobulin light chains by cardiomyocytes in AL amyloidosis: what can biopsies tell us?
2024-7-7
Outcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapy
2024-7-2
Transthyretin monomers: a new plasma biomarker for pre-symptomatic transthyretin-related amyloidosis
2024-7-1
Identification of isoaspartate-modified transthyretin as potential target for selective immunotherapy of transthyretin amyloidosis
2024-5-27
Genetic counselling for at-risk family members with hereditary transthyretin amyloidosis: data from a single-centre study
2024-5-25
1. Daily life in patients with hereditary transthyretin amyloidosis: a qualitative study
2024-5-23
Gastrointestinal Amyloid Screening Study (GASS): is screening for amyloid in the gastrointestinal tract useful?
2024-5-21
Absence of an increased wall thickness does not rule out cardiac amyloidosis
2024-5-20
Patient-reported satisfaction with telemedicine in light chain (AL) amyloidosis care
2024-5-20
Double pathogenic variant in an ATTRv patient with mixed phenotype
2024-5-16
Heterogeneity in families with ATTRV30M amyloidosis: a historical and longitudinal Portuguese case study impact for genetic counselling
2024-4-8
Changes in the amyloid editorial board members and in editor positions
2024-4-2
Longitudinal analysis of serum neurofilament light chain levels as marker for neuronal damage in hereditary transthyretin amyloidosis
2024-3-13
Circulating transthyretin and retinol binding protein 4 levels among middle-age V122I <i>TTR</i> carriers in the general population
2024-3-6
Possible transmission of leukocyte chemotactic factor 2 amyloidosis after interpopulational liver transplantation
2024-3-5
Gait abnormalities in older adults with transthyretin cardiac amyloidosis
2024-3-3
Serum neurofilament light chain in hereditary transthyretin amyloidosis: validation in real-life practice
2024-2-13
Mass spectrometry-based proteomic analysis of proteins adsorbed by hexadecyl-immobilized cellulose bead column for the treatment of dialysis-related amyloidosis
2024-2-11
Sequence diversity of kappa light chains from patients with AL amyloidosis and multiple myeloma
2024-1-11
Symptomatic SARS-CoV2 infection associated with high mortality in AA amyloidosis
2023-12-21
Dual AApoAIV amyloidosis and ATTR amyloidosis arising in the same patient: a report of three cases
2023-12-15
Neurofilament light chain kinetics as a biomarker for polyneuropathy in V122I hereditary transthyretin amyloidosis
2023-12-11
Longitudinal evolution of ventricular function and cardiac magnetic resonance imaging tissue characteristics in tafamidis-treated transthyretin amyloid cardiomyopathy
2023-12-9
Longitudinal PET/CT imaging with iodine ( <sup>124</sup> I) evuzamitide reveals organ response to plasma cell immunotherapy in a patient with AL amyloidosis
2023-11-22
Identification of calcitonin receptor-stimulating peptide 1-derived amyloid in a feline C-cell carcinoma
2023-11-19
AA amyloidosis in a father and daughter as complication of <i>PSTPIP1</i> -associated myeloid-related proteinemia inflammatory (PAMI) syndrome
2023-10-23
Hereditary transthyretin amyloidosis in middle-aged and elderly patients with idiopathic polyneuropathy: a nationwide prospective study
2023-10-19
The way to a man’s heart: prostate samples for the early detection of transthyretin cardiomyopathy
2023-10-11
Inappropriate use of technetium-99m pyrophosphate scanning for the evaluation of transthyretin amyloidosis
2023-10-6
Heterogeneous worldwide access and pricing of Tafamidis
2023-10-3
Intra-familial variability of oculoleptomeningeal amyloidosis due to the ATTR I107M (c.381T > G) mutation: diagnostic challenges of a rare phenotype
2023-9-27
Patient-reported outcome measures for transthyretin cardiac amyloidosis: the ITALY study
2023-9-5
Reduction in <sup>99m</sup> Tc-DPD myocardial uptake with therapy of ATTR cardiomyopathy
2023-8-20
Correction
2023-8-10
Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis
2023-8-2
Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis
2023-7-26
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远